Long-term efficacy for lebrikizumab seen in moderate, severe eczema
For patients with moderate-to-severe atopic dermatitis (AD), lebrikizumab has long-term efficacy, according to a study presented at the annual meeting
For patients with moderate-to-severe atopic dermatitis (AD), lebrikizumab has long-term efficacy, according to a study presented at the annual meeting
Kensington’s first Thunderbolt 5 dock, the future of PC I/O, is here! Unfortunately, it’s just one part of the equation.
I’ve spent a significant part of my career exploring and documenting how ecosystems function, and the profound impact humanity has
A NASA spacecraft erected a large, foil solar sail in orbit around Earth last week, after a failed attempt days
Even as fall flu season approaches and COVID-19 cases rise nationally, the biggest contagion threat facing the United States may
No posts found.